PDGF-C induces maturation of blood vessels in a model of glioblastoma and attenuates the response to anti-VEGF treatment.
Recent clinical trials of VEGF inhibitors have shown promise in the treatment of recurrent glioblastomas (GBM). However, the survival benefit is usually short-lived as tumors escape anti-VEGF therapies. Here we tested the hypothesis that Platelet Derived Growth Factor-C (PDGF-C), an isoform of the P...
Main Authors: | Emmanuelle di Tomaso, Nyall London, Daniel Fuja, James Logie, James A Tyrrell, Walid Kamoun, Lance L Munn, Rakesh K Jain |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2662415?pdf=render |
Similar Items
-
PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma
by: Tianrun Liu, et al.
Published: (2018-08-01) -
Rat Hippocampal Neural Stem Cell Modulation Using PDGF, VEGF, PDGF/VEGF, and BDNF
by: Neus Gomila Pelegri, et al.
Published: (2019-01-01) -
Hypoxia, PDGF and VEGF in Vascular Development
by: Nilsson, Ingrid
Published: (2006) -
Rationale for targeting VEGF, FGF, and PDGF for the treatment of NSCLC
by: Ballas MS, et al.
Published: (2011-05-01) -
Accelerated and Improved Vascular Maturity after Transplantation of Testicular Tissue in Hydrogels Supplemented with VEGF- and PDGF-Loaded Nanoparticles
by: Federico Del Vento, et al.
Published: (2021-05-01)